Science at the Core: Key Trends Shaping Cosmetic Ingredient Innovation in 2026

Science at the Core: Key Trends Shaping Cosmetic Ingredient Innovation in 2026

The global personal care industry gathered in Paris this May for In-Cosmetics Global 2026, the sector’s premier ingredient showcase. Under the theme “Science as the Core, Beauty Reborn,” the event brought together over 1,100 exhibitors and 16,000 professional visitors to map the next generation of cosmetic science. The developments on display — and the regulatory shifts accompanying them — offer a clear window into where formulation technology is heading this year.

1. AI-Driven Formulation Moves from Lab Tool to Core Engine

The most significant story to emerge this season is the transition of artificial intelligence from an auxiliary research tool to a central engine of ingredient discovery and formulation design. At the 2026 China Cosmetics Science and Technology Conference in Guangzhou (May 21–22), Nobel laureate Professor Michael Levitt presented his work on AI applications in the development of Cell泌素 HME. The technology uses AI to screen and simulate exosome-like structures that mimic biological mechanisms found in the human body, reproducing cellular youth-extension pathways. This marks the first global translation of Levitt’s Nobel-winning research into a skincare application.

Separately, technical disclosures from formulation labs in China detail multi-engine adaptive algorithms that use big-data analysis and machine learning to dynamically adjust formulations and production parameters based on real-world client feedback. Published technical briefs claim the algorithm raises formulation adjustment accuracy above 95% while shortening development cycles. A real-time algorithm synchronization mechanism is also reported to improve production efficiency by 20% and reduce defect rates by 15%. While independent verification of these figures is limited, the direction of travel is clear: AI is becoming embedded in the formulation workflow itself, not just the research phase.

Source: 创新重塑价值,2026中国化妆品科学技术大会在广州举办 (2026-05-23)

2. In-Cosmetics Global 2026: Plant Extracts and Chinese Innovation on the World Stage

At In-Cosmetics Global 2026 in Paris, the scale of the event itself signaled the industry’s continued investment in ingredient innovation despite a challenging macro environment. Among the exhibitors, Yunnan Special Plant Extraction Laboratory — part of the Botanee Group — drew significant attention for its independently developed plateau plant extracts, showcasing how Chinese cosmetic science is moving from follower to contributor in the global ingredients space.

The parallel In-Cosmetics Korea 2026 awards, announced earlier this year, reinforced the momentum behind K-beauty ingredient innovation. Three dedicated award categories — the Innovation Zone Best Ingredient Award, the K-Beauty Standout Award, and the new K-Innovative Ingredient Award — recognized ingredients judged on performance, global impact, and Korea-led innovation. The awards highlight a broader trend: regional ingredient differentiation is becoming a competitive battleground, with localized botanicals and biotechnology-derived actives leading the way.

Source: In-Cosmetics Global 2026: 贝泰妮云南特植实验室展现中国植萃创新实力 (2026-05-13)

Source: In-Cosmetics Korea Awards — Innovation Zone Best Ingredient Award

3. Regulatory Update: EU SCCS Issues Final Opinion on CBD, Korea Expands Analytical Methods

Regulatory frameworks for cosmetic ingredients continue to evolve in 2026, with two notable developments in April.

The European Union’s Scientific Committee on Consumer Safety (SCCS) issued its final opinion on the use of cannabidiol (CBD) in cosmetic products in April 2026, concluding a multi-year safety assessment process. The opinion provides definitive guidance for brands formulating with CBD in the EU market and is expected to influence regulatory approaches in other jurisdictions.

Separately, South Korea’s National Institute of Food and Drug Safety Evaluation (NIFDS) released a draft revision to its “Guidelines for Analytical Methods for Cosmetic Usage Limit Ingredients” on April 21, 2026, adding 18 new analytical methods and revising existing protocols for triclosan and zinc pyrithione testing. The public comment period closed April 24. For brands exporting to South Korea, the expanded analytical methods mean tighter compliance requirements for ingredient testing and documentation.

Source: SCCS Issued Final Opinion on Cannabidiol (CBD) Used in Cosmetic Products (2026-05-07)

Source: Korea Adds 18 New Cosmetic Ingredient Analytical Methods; Triclosan & Zinc Pyrithione Tests Revised (2026-05-07)

4. Delivery System Technology: From Concept to Measurable Performance

Behind the headline ingredient stories, a quieter but equally important trend is unfolding in delivery system technology. Formulation scientists are increasingly focusing on how actives are delivered to the skin, not just which actives are used. Conference programming at In-Cosmetics Global 2026 emphasized encapsulation technologies, liposomal delivery, and carrier systems designed to improve stability and bioavailability of sensitive actives such as peptides and botanically derived compounds.

The business case for advanced delivery systems is strengthening as well. With consumer scrutiny of ingredient claims at an all-time high, brands are looking to delivery technology as a way to differentiate efficacy stories with measurable data. Investment in delivery system R&D is expected to outpace investment in new active discovery through the remainder of 2026.

Outlook

The convergence of AI-driven formulation, biotechnology-derived actives, and tightening global regulatory frameworks is reshaping the competitive landscape for cosmetic ingredients in 2026. For R&D teams, the takeaway is practical: formulation speed and claims substantiation are both accelerating, and the brands that treat ingredient science as a core capability — not a procurement decision — are the ones setting the pace.